Methyltransferase inhibitors: changing the treatment algorithm for myelodysplastic syndromes

Cancer Control. 2004 Nov-Dec;11(6 Suppl):16-9. doi: 10.1177/10732748040110S605.
No abstract available

Publication types

  • Review

MeSH terms

  • Age Factors
  • Azacitidine / therapeutic use
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Methyltransferases / antagonists & inhibitors*
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / drug therapy*
  • Patient Selection
  • Practice Guidelines as Topic*
  • Risk Assessment / methods
  • Stem Cell Transplantation

Substances

  • Enzyme Inhibitors
  • Methyltransferases
  • Azacitidine